Smart-Money SignalNeutral · 46/100— Insiders are net buyers over 90 days ($106K, 11 buys vs 4 sales)
Revenue$41.6M
Net Income-$3.4M
EPS$-0.20
Gross Margin51.1%
Market Cap$227.1M
Price Performance
Historical data including institutional events
Company Profile
K
Keith J. Sullivan
CEO & Executive Director
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
